Hyperphosphatemia Industry is projected to reach USD 20.24 Billion by 2033: Propelled by ESRD Prevalence | FMI
The worldwide hyperphosphatemia industry is anticipated to reach a valuation of around USD 12.66 billion
The worldwide hyperphosphatemia industry is anticipated to reach a valuation of around USD 12.66 billion
The fight against hyperphosphatemia, a condition characterized by excess phosphate in the blood, is poised